Response to comments from Drs. Alter and Rosenberg.
Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada yigal.dror@sickkids.ca.
Yigal
Y
Dror
Marrow Failure and Myelodysplasia Program, Division of Hematology/Oncology, Department of Paediatrics and the Genetics and Genome Biology Program, Research Institute, The Hospital for Sick Children and the University of Toronto, Ontario, Canada.
Michaela
M
Cada
D002471:Cell Transformation, Neoplastic / Q000235:genetics*; D002869:Chromosome Aberrations; D060965:Clonal Evolution; D006457:Hemoglobinuria, Paroxysmal / Q000151:congenital* / Q000175:diagnosis*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000209:etiology*
CCC classification; clonal and malignant myeloid transformation; inherited bone marrow failure syndromes